Qualitative Validation of a Novel VR Program for Irritable Bowel Syndrome: A VR1 Study.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35020674.
- Also identified by DOI 10.14309/ajg.0000000000001641.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although gut-directed psychotherapies are effective for irritable bowel syndrome (IBS), they are rarely prescribed, given a paucity of trained clinicians. Virtual reality (VR) offers a solution by allowing patients to self-practice these techniques in a standardized manner. A multidisciplinary team developed IBS/VR, a program that transports users into immersive VR worlds that teach patients about the brain-gut axis, cognitive behavioral therapy, and gut-directed meditation. We tested IBS/VR in Rome IV IBS patients and used inductive analysis to evaluate perceptions and identify recommendations. We achieved thematic saturation after 9 interviews; 3 additional interviews revealed no emergent themes. After making 23 software changes based on patient feedback, we conducted 3 additional interviews which confirmed thematic saturation (N = 15 total). This study offers initial validation of the first VR program designed for IBS.
Medical subject headings
- Cognitive Behavioral Therapy
- Irritable Bowel Syndrome
- Meditation
- Virtual Reality